Analysis of Relationship Between Imaging Features of Aortic Dissection and Blood Parameters

Abstract

Aimed to evaluate the relationship of serum biochemical and blood parameters with aortic rupture and dissection types according to the DeBakey classification. Methods: Forty-three patients, who were admitted to the emergency department between 01.01.2011 and 01.01.2019 with the diagnosis of aortic dissection, were retrospectively evaluated. Gender, age, symptoms at presentation, vital parameters, creatinine and, troponin levels, and hemogram parameters were recorded after blood tests. Neutrophil-tolymphocyte ratio and monocyte-to-platelet ratio were obtained from these values. These results were compared with the presence of aortic rupture and the DeBakey classification. Results: Of the 43 patients included in the study, 30 were male (69.8%), and 13 were female (30.2%). Aortic rupture was seen in two of the 30 male patients (6.7%) and none of the females (p=1.000). There was a significant difference only in blood urine nitrogen and monocyte-to-platelet ratio between patients with and without aortic rupture (p=0.035 and p=0.015, respectively). Conclusion: Most of the routinely evaluated blood and biochemical parameters in aortic dissection cases did not yield significant results in comparison to the DeBakey classification and the presence of rupture. Only blood urea nitrogen and monocyte-to-platelet ratio values were lower in patients with aortic rupture.

Comparison of the monocyte-to-HDL cholesterol ratio between patients with STEMI and NSTEMI: A retrospective observational study

“…Along with the developing technologies in diagnostic and treatment modalities and the increase in survival in patients with acute coronary syndrome, the importance of the early diagnosis of diseases and modification of risk factors has increased [2]. Researchers have studied many biochemical markers, such as hematological parameters, D-lactate, intestinal fatty acid-binding protein, and ischemia-modified albumin and scoring systems, including GRACE, SYNTAX, and Gensini scores in the diagnosis and risk scoring of patients [1][2][3][4][5]. Moreover, emerging biochemical markers provide better complementary information in risk assessment, although there is still a need to better recognize the pathophysiology of ACS and develop a specific treatment [6].…”